Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

白蛋白-胆红素评分在肝脏疾病中的应用进展

宋丽,朴顺梅,姚红,樊健,程昱,卢宝玲,于雷

Journal of Clinical Internal Medicine（2022）

Cited 0|Views24
No score
Abstract
白蛋白-胆红素(ALBI)评分是依据日本肝细胞癌(HCC)患者临床生存资料建立的新型肝功能评价模型,具有良好的肝功能评估及预后预测表现.本文主要介绍ALBI评分在病毒性肝炎、肝硬化、慢加急性肝衰竭、原发性胆汁性胆管炎、HCC和肝内胆管癌中应用现状,认为ALBI评分不仅可用于HCC,在其他肝脏疾病中与已有评价模型相比同样表现良好且具有应用优势.
More
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined